CLaCS

From Wikipedia, the free encyclopedia

CLaCS (Cryo-Laser and Cryo-Sclerotherapy) is a treatment for leg vein lesions by combining transdermal laser effect and injection sclerotherapy, all under skin cooling (Cryo - cold air blown onto the skin at -20C).[1][2][3] The laser causes a selective photothermolysis damaging the vein wall. The vein's lumen gets smaller. On a second procedure, sclerosing agent is injected where the vein is still open. This combination can be used treat veins that could be treated by phleboectomy or foam sclerotherapy - more invasive options. To improve results, CLaCS can be guided by Augmented Reality[4] (near-infrared vein finder).[5]

CLaCS was created by Dr. Roberto Kasuo Miyake (also knowns as Kasuo Miyake), in 1999, to adhere to patients' requests for treatment that did not require hospitalizations.[3]

References[edit]

  1. ^ Cryo-laser and cryo-sclerotherapy guided by augmented reality for telangiectasias, feeder, and small varicose vein treatment–The CLaCS technique white paper report RK Miyake, E Ramacciotti J Phlebol Lymphol 12 (1), 1-7 https://scholar.google.com/citations?view_op=view_citation&hl=pt-BR&user=N96fCRUAAAAJ&citation_for_view=N96fCRUAAAAJ:BrmTIyaxlBUC
  2. ^ State of the art on cryo-laser cryo-sclerotherapy in lower limb venous aesthetic treatment
  3. ^ a b Miyake, Hiroshi; Miyake, Kasuo; Duarte, Flávio; Kikuchi, Rodrigo (2008). "Pequenas Varizes e Telangiectasias" [Small Varicose Veins and Telangiectasias]. Doenças Vasculares Periféricas (in Portuguese). 2 (4 ed.). Rio de Janeiro, RJ: Guanabara Koogan S.A.: 1769–1795. ISBN 9788527714600.
  4. ^ Reality, only better, December 8th https://www.economist.com/letters-to-the-editor-the-inbox/2007/12/19/reality-only-better-december-8th
  5. ^ Miyake, RK; Zeman, HD; Duarte, FH; Kikuchi, R; Ramacciotti, E; Lovhoiden, G; Vrancken, C (2014-01-24). "Vein imaging: a new method of near infrared imaging, where a processed image is projected onto the skin for the enhancement of vein treatment". Dermatol Surg. 32 (8): 1031–8. doi:10.1111/j.1524-4725.2006.32226.x. PMID 16918565. S2CID 8872471.